Page last updated: 2024-08-21

2-piperidone and Hematologic Neoplasms

2-piperidone has been researched along with Hematologic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Hoffmann, M; Li, Y; Liu, L; MacGorman, K; Palmisano, M; Zhou, S1

Trials

1 trial(s) available for 2-piperidone and Hematologic Neoplasms

ArticleYear
Single-Dose Pharmacokinetics, Safety, and Tolerability of Avadomide (CC-122) in Subjects With Mild, Moderate, or Severe Renal Impairment.
    Clinical pharmacology in drug development, 2020, Volume: 9, Issue:7

    Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Carcinoma, Hepatocellular; Case-Control Studies; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Genetic Pleiotropy; Glioblastoma; Hematologic Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Piperidones; Quinazolinones; Renal Insufficiency; Safety; Severity of Illness Index; Ubiquitin-Protein Ligases

2020